Surgical Pulmonary Valve Replacement in Adults with Congenital Heart Disease
Author Information
Author(s): Kana Kubota, Gerhard-Paul Diller, Aleksander Kempny, Andreas Hoschtitzky, Yasushi Imai, Masaaki Kawada, Darryl Shore, Michael A. Gatzoulis
Primary Institution: Royal Brompton Hospital, London, United Kingdom
Hypothesis
What is the impact of prosthesis type on outcomes after surgical pulmonary valve replacement?
Conclusion
Surgical pulmonary valve replacement is associated with low early mortality and no significant differences in reoperation rates between different types of prostheses.
Supporting Evidence
- Early mortality rates were low at 1.4%.
- Freedom from re-intervention rates were 99.8%, 96.6%, 90.2%, and 81.0% at 1, 5, 10, and 15 years, respectively.
- 27 patients (5.5%) required re-intervention during a mean follow-up of 6.5 years.
- Survival rates at 1, 5, 10, and 15 years were 98.3%, 97.7%, 96.8%, and 95.4%, respectively.
- Mosaic valves required earlier re-intervention compared to Perimount valves.
Takeaway
Doctors replaced heart valves in 490 adults with heart problems, and most did well after surgery, with very few needing more surgery later.
Methodology
Retrospective analysis of surgical pulmonary valve replacements performed between January 2003 and December 2018.
Limitations
The study is retrospective and has a relatively short follow-up period.
Participant Demographics
490 patients, mean age 29.9 years, 40% women.
Statistical Information
P-Value
p=0.047
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website